Login to Your Account



Pharma: Other News To Note


Friday, September 7, 2012
• Abbott, of Abbott Park, Ill., said it signed a deal with Tokyo-based Astellas Pharma Inc. to collaborate on a Phase III trial testing ASP0113 (TransVax), an investigational vaccine licensed from Vical Inc., of San Diego, for preventing cytomegalovirus (CMV) reactivations in transplant patients.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription